Back to Search Start Over

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

Authors :
Gaetano Verde
Verónica Rodilla
David Andreu
Riccardo Aiese Cigliano
Ane Iturbide
Jessica Querol
Paolo Nuciforo
Walter Sanseverino
Joaquín Arribas
Travis H. Stracker
José Yélamos
M. Cosín
Sandra Segura-Bayona
Gemma Serra-Bardenys
Joan Pau Cebrià-Costa
Cristina Bernadó-Morales
Sandra Peiró
Abel Gonzalez-Perez
Laura Pascual-Reguant
A García de Herreros
Institut Català de la Salut
[Cebrià-Costa JP, Pascual-Reguant L, Serra-Bardenys G, Querol J, Cosín M, Nuciforo P, Rodilla V, Peiró S] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gonzalez-Perez A] Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. [Verde G] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. [Bernado-Morales C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Centro de Investigación Biomédica en Red en Oncología (CIBERONC), 08035 Barcelona, Spain. [Arribas J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Centro de Investigación Biomédica en Red en Oncología (CIBERONC), 08035 Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain
Vall d'Hebron Barcelona Hospital Campus
Source :
Oncogene 39, 79-121 (2020), Dipòsit Digital de Documents de la UAB, Universitat Autònoma de Barcelona, Oncogene, Scientia
Publication Year :
2020
Publisher :
Nature Publishing Group, 2020.

Abstract

Cromosomes; Marcadors pronòstics Cromosomas; Marcadores de pronóstico Chromosomes; Prognostic markers Oxidation of H3 at lysine 4 (H3K4ox) by lysyl oxidase-like 2 (LOXL2) generates an H3 modification with an unknown physiological function. We find that LOXL2 and H3K4ox are higher in triple-negative breast cancer (TNBC) cell lines and patient-derived xenografts (PDXs) than those from other breast cancer subtypes. ChIP-seq revealed that H3K4ox is located primarily in heterochromatin, where it is involved in chromatin compaction. Knocking down LOXL2 reduces H3K4ox levels and causes chromatin decompaction, resulting in a sustained activation of the DNA damage response (DDR) and increased susceptibility to anticancer agents. This critical role that LOXL2 and oxidized H3 play in chromatin compaction and DDR suggests that functionally targeting LOXL2 could be a way to sensitize TNBC cells to conventional therapy. This work was supported by grants from Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI12/01250; CP08/00223; PI16/00253; and CB16/12/00449), MINECO (SAF2013-48849-C2-1-R) to SP, BFU2015-68354 to THS, Breast Cancer Research Foundation (BCRF-17-008) to JA, AGL2014-52395-C2-2-R to DA, Worldwide Cancer Research, Red Temática de Investigación Cooperativa en Cáncer (RD012/0036/005), Fundación Científica de la Asociación Española contra el Cáncer, and Fundació La Marató TV3. THS was supported by institutional funding (MINECO) through the Centres of Excellence Severo Ochoa award and the CERCA Programme of the Catalan Government, and SS-B, by a Fundació La Caixa fellowship. We thank La Caixa Foundation and Cellex Foundation for provide research facilities and equipment. GV has received funding from the MINECO (a “Juan de la Cierva Incorporation” fellowship; IJCI-2014-20723). SP was a recipient of a Miguel Servet contract (ISCIII/FIS), and AI, JPC-C, LP-G, and GS-B are supported by contracts from Worldwide Cancer Research, Fundació La Marató TV3, Fundació FERO, and a FI Fellowship from the Generalitat de Catalunya, respectively.

Details

Language :
German
Database :
OpenAIRE
Journal :
Oncogene 39, 79-121 (2020), Dipòsit Digital de Documents de la UAB, Universitat Autònoma de Barcelona, Oncogene, Scientia
Accession number :
edsair.doi.dedup.....daabe112cd5499be77ca94ee16d69ec5